Member Info for Mistral77

I warned you about this two weeks ago, and you just used foul language in response.

Two weeks ago!

Cheers tricky,

All makes sense.

Short term upside of the RTC but with the Mologic tie up to properly set the omega business free.

Great find. Looks like Abingdon are wanting to hoover up as much of that 10bn global test market as they can.

As Abingdon are the test developer and are then going to share at ‘design freeze’ to the others in the RTC, who will hold the IP? Will ODX be allowed to use Abingdon’s test to compete with Abingdon for sales outside of ODX’s responsibility to supply UK gov Scotland?

Do you have level 2 access on LSE. If not it is very good.

Every buy is also a sell, it just depends which side of the mid point the trade is priced at, that defines if it is recorded as a buy or sell.

Maybe dropping for a placing to cover the £8mill.

I am positive about the further Mologic tie-up. It creates another route to market alongside the RTC. Especially as it looks like Abingdon are leading it.

They must be being fed the news that we aren’t.

I would have secured a launch customer, even if I had to induce the deal.

You would think that in order to ask for £48 million of hard earned cash you would actually produce a test? Even if it was a lab based one that everyman and his dog currently has.

I am not sure good old Al is in charge anymore, Boohoo.

https://news.sky.com/story/coronavirus-99-chance-that-covid-19-vaccine-will-work-says-chinese-firm-11996787

Did you see this link from earlier today regarding Sinovac carrying out the phase 3 trial in the UK. Not sure where else they could do it but Hvivo.

AT least CF at ORPH waited until he had a test to sell before placing.

Not in the MM’s interest to see this drop though until the placing. Wouldn’t please the ii’s.

He is a total outright liar. He was asked a specific question during the video session about future placing and he gave a very specific answer, “no”.

The POC test is further off than ODX’s.

8am RNS?

More narcs than an 80’s rave in your list of pharmas.
Depends on what fix you are looking for; therapy, cure, rapid antigen test, not so rapid antigen test, rapid antibody test, not so rapid antibody test and lots of good old snake oil.

Steer clear of any stocks that are under the tractor beam of the bumbling uk government.

You don’t want to be out for too long though!!

Fortunately, we are not relying on the buffoonery of Boris’s UK government, as our marketplace is elsewhere. But I am sure that we will sell them some tests if they ask nicely.

Likewise, just taken some profit.

These things always drop back a bit from major milestones.

And Roche need some a lab

Always good to pocket the spoils. Definitely leave some in for the ‘point of care’ rapid antibody test that is coming in a few weeks. That is a global game changer.

WarrenB,

We are almost certainly sitting on the edge of the next FTSE bear trap, so you will inevitably see a bigger loss in BT over the coming weeks. That doesn’t make BT a bad company or a bad investment in the long term. You could:
1. Stick with it, ride it down, don’t sell BT therefore not crystalising your loss. Give it a couple of years and you will recover. Just don’t look at the share price every day.
2. Sell BT now, let them drop into the next bear trap and then buy them back at a cheaper price. Whence more shares.
3. Keep your BT but Use extra cash to invest into BATM/AZN/GSK to make money on the Covid pharma bubble. Set a target price on the pharma stocks and sell on the rise, covid will only attract a premium for six to twelve months. That said, the money that some companies make in that period, will be the making of them.
4. Cash in the BT, crystalise your loss, buy into the Covid pharma bubble. By this time next year we will be millio...........:

Thanks for the link.